Category: Oral Medication

Invokana for Type 1 diabetes

Invokana Helps My Type 1 Diabetes

I emailed my endo ahead of time to give her a heads up that I wanted to discuss going on Invokana. Unfortunately, she wasn't familiar with use of Invokana in Type 1 diabetes, or how insulin should be adjusted when on it. I sent her all of the research articles I could find related to Type 2 therapies being explored for Type 1. Luckily for me, and much to her credit, she was willing to prescribe it to me off label to give it a try.
0 Shares
Using Type 2 Medication to Treat Type 1 Diabetes

Using Type 2 Diabetes Medication to Treat Type 1 Diabetes

There have been a number of new developments in the treatment of type 2 diabetes, and a question often asked is whether some of the type 2 therapies might be beneficial for people with type 1 diabetes. For example, several years ago, one of my patients with type 1 diabetes was having trouble with weight and with blood glucose control on a basal-bolus insulin combination. We added metformin, and his blood sugars appeared to get a bit better.
0 Shares
Lilly - Boehringer - logo

FDA Issues Complete Response Letter for Type 2 Diabetes Drug Empagliflozin

The FDA has issued a complete response letter to Boehringer Ingelheim and Eli Lilly for the New Drug Application (NDA) of the investigational sodium glucose co-transporter-2 (SGLT2) inhibitor empagliflozin. The complete response letter referenced previously observed deficiencies at a Boehringer Ingelheim facility where empagliflozin will be manufactured.
0 Shares
Bristol-Myers Squibb - AstraZeneca Logo

FDA Advisory Committee Votes In Favor of NewType 2 Diabetes Drug, Dapagliflozin.

The FDA's Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has decided (13-1) in favor of Bristol-Myers Squib and AstraZeneca's type 2 diabetes drug, dapagliflozin. The committeee found that the benefits of dapagliflozin use outweigh identified risks and support marketing of dapagliflozin as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
0 Shares
gsk-logo

Avandia Restriction Lifted by FDA

The U.S. FDA has lifted certain restrictions on prescribing and use of the diabetes drug Avandia (rosiglitazone) to reflect new information regarding the cardiovascular risk of the medicine.
0 Shares
NIH Logo

Volunteers Needed for NIH Diabetes Study

If you've been diagnosed with type 2 diabetes in the last 5 years, you may be eligible to help scientists test treatments by participating in an NIH study. NIH has launched a long-term clinical trial called the GRADE study. Researchers will examine the benefits and risks of common diabetes drugs used with metformin.
0 Shares